BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAD3. A total of 7 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $34,000 | +6.2% | 8,000 | 0.0% | 0.00% | – |
| Q4 2016 | $32,000 | -11.1% | 8,000 | 0.0% | 0.00% | – |
| Q3 2016 | $36,000 | +33.3% | 8,000 | +14.3% | 0.00% | – |
| Q2 2016 | $27,000 | -3.6% | 7,000 | 0.0% | 0.00% | – |
| Q1 2016 | $28,000 | +180.0% | 7,000 | +250.0% | 0.00% | – |
| Q4 2015 | $10,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2015 | $10,000 | -23.1% | 2,000 | 0.0% | 0.00% | – |
| Q2 2015 | $13,000 | +8.3% | 2,000 | 0.0% | 0.00% | – |
| Q1 2015 | $12,000 | +50.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2014 | $8,000 | +14.3% | 2,000 | 0.0% | 0.00% | – |
| Q3 2014 | $7,000 | +16.7% | 2,000 | 0.0% | 0.00% | – |
| Q2 2014 | $6,000 | -14.3% | 2,000 | 0.0% | 0.00% | – |
| Q1 2014 | $7,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2013 | $7,000 | -86.0% | 2,000 | -85.7% | 0.00% | – |
| Q3 2013 | $50,000 | – | 14,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Amici Capital, LLC | 8,000,000 | $35,720,000 | 1.61% |
| Baker Brothers Advisors | 22,898,000 | $102,104,000 | 1.04% |
| CITIGROUP INC | 6,176,000 | $27,560,000 | 0.02% |
| SG Americas Securities, LLC | 10,000 | $4,465,000 | 0.02% |
| SSI INVESTMENT MANAGEMENT LLC | 37,000 | $165,000 | 0.02% |
| GEODE CAPITAL MANAGEMENT, LLC | 1,000,000 | $4,462,000 | 0.00% |
| Allianz Asset Management GmbH | 300,000 | $1,340,000 | 0.00% |
| UBS Group AG | 22,000 | $98,000 | 0.00% |
| ROYAL BANK OF CANADA | 2,000 | $8,000 | 0.00% |
| MORGAN STANLEY | 11,000 | $49,000 | 0.00% |